Chemical inhibitors of BC046404 include a range of compounds that interfere with various signaling pathways and enzymatic activities, which are essential for the functional activity of this protein. Staurosporine is a potent protein kinase inhibitor with broad specificity, and the inhibition of these kinases can lead to the functional suppression of BC046404, particularly if it relies on phosphorylation events for its activity. LY294002, on the other hand, targets the PI3K/Akt signaling pathway, a crucial route for regulating cell survival and metabolism. This chemical's inhibitory action can suppress BC046404 if it operates downstream or is regulated by PI3K/Akt. Similarly, rapamycin's inhibition of mTOR, a central regulator of cell growth and metabolism, can impede BC046404 function if it is linked to the mTOR pathway. PD98059 and SB203580 selectively inhibit the MEK/ERK and p38 MAP kinase pathways, respectively. These pathways are commonly associated with cell proliferation, stress responses, and inflammation, and their inhibition can suppress BC046404 if it is part of these signaling networks.
Further inhibitors such as PP2 and Dasatinib selectively target Src family tyrosine kinases and can suppress BC046404 if it is modulated by Src kinase signaling. Sorafenib's inhibition of multiple kinases, including RAF, also offers a route to inhibit BC046404 if it is involved in pathways regulated by RAF kinase activity. JNK signaling can be inhibited by SP600125, which would impact BC046404 if it is associated with the JNK pathway. ZM447439, which inhibits Aurora kinases involved in cell cycle regulation, can suppress BC046404 if it is linked to cell cycle progression. Lestaurtinib targets JAK2 kinase and can suppress BC046404 if it is a part of JAK-STAT signaling, a pathway crucial for a range of cellular processes including immune response and cell growth. Lastly, PD173074 inhibits FGFR kinase activity, and this can lead to the inhibition of BC046404 if it is regulated by FGFR signaling pathways. Each of these chemicals acts upon specific enzymes or pathways to exert their inhibitory effect on BC046404, reflecting a diverse set of mechanisms by which the functional activity of BC046404 can be restrained.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine inhibits a wide range of protein kinases, which can lead to the functional inhibition of BC046404 if this protein's activity is dependent on phosphorylation by specific kinases that staurosporine targets. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is an inhibitor of PI3K, which could result in the functional inhibition of BC046404 by attenuating PI3K/Akt signaling, assuming the protein's activity is regulated by this pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR, which can lead to the inhibition of BC046404 if the protein is regulated by mTOR signaling related to cell growth and autophagy. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 selectively inhibits MEK1/2, and thus can functionally inhibit BC046404 if this protein's function is mediated by the MEK/ERK signaling pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is a p38 MAP kinase inhibitor that can inhibit BC046404 if the protein's function is associated with the p38 MAPK stress response pathway. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
PP2 inhibits Src family tyrosine kinases, which would functionally inhibit BC046404 if the protein's activity is regulated by Src kinase signaling. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Dasatinib, a Src kinase inhibitor, can inhibit BC046404 if the protein is regulated by Src family kinases within its signaling network. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
Sorafenib targets multiple kinases, including RAF, which can lead to inhibition of BC046404 if RAF kinase signaling modulates this protein's function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, which can functionally inhibit BC046404 if the protein's activity is regulated by JNK signaling pathways. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $150.00 $349.00 | 15 | |
ZM447439 is an Aurora kinase inhibitor, which can inhibit BC046404 if the protein is involved in cell cycle regulation and modulated by Aurora kinase activity. |